CEACAM AVI-HIS-TAG

Catalog No.: C005B-306673
Mfr. No.: SRP0502-100UG
Mfr. Name: Sigma-Aldrich
Qty/UOM: 1
UOM: EA

Price: $907.48

List Price: $1,008.32

General description Human CEACAM, also known as Carcinoembryonic antigen-related cell adhesion molecule 1 or biliary glycoprotein, (GenBank Accession No. NM_ 001712), amino-acids 35-428, with C-terminal Avi-His-tag, MW = 47 kDa, expressed in

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

General description

Human CEACAM, also known as Carcinoembryonic antigen-related cell adhesion molecule 1 or biliary glycoprotein, (GenBank Accession No. NM_ 001712), amino-acids 35-428, with C-terminal Avi-His-tag, MW = 47 kDa, expressed in HEK293 cells. This protein runs at a higher M.W. by SDS-PAGE due to glycosylation.

Physical form

Aqueous solution

Legal Information

AviTag is a trademark of Avidity, LLC

Shipping Information:

Dry Ice Surcharge & Ice Pack Shipments: $40

More Information: https://cenmed.com/shipping-returns

UPC:: 12352200
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: SRP0502-100UG
Temperature Control Device:: Yes

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."